Natural history of medullary thyroid carcinoma in MEN 2 patients carrying a variant at codon 804 in the RET proto-oncogene: A study by the French Neuroendocrine Tumor Group (GTE)
Valentine Suteau(Centre Hospitalier Universitaire d'Angers), Claire Briet(Centre Hospitalier Universitaire d'Angers), G. Chabrier(Hôpitaux Universitaires de Strasbourg), Maëlle Le Bras(Hôpital Laennec), Martin Schlumberger(Institut Gustave Roussy), Nicolas Chevalier(Inserm), M. Lebeault(Centre Hospitalier Universitaire d'Angers), Hélène Lasolle(Université Libre de Bruxelles), C. Ghander, Patrice Rodien(Inserm), V. Rohmer(University of Pisa), Delphine Mirebeau-Prunier(Centre Hospitalier Universitaire d'Angers), Philippe Caron(Centre Hospitalier Universitaire de Toulouse), I. Raingeard(Centre Hospitalier Universitaire de Montpellier), Mohamed Zalzali(Centre Hospitalier Universitaire de Reims), Frédéric Castinetti(Inserm)
Cited by 5
Related Papers
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
|New England Journal of Medicine|2012|863
Human Health and Ocean Pollution
|Annals of Global Health|2020|751
Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation
|The Lancet|2004|707
Prognostic Factors for Persistent or Recurrent Disease of Papillary Thyroid Carcinoma with Neck Lymph Node Metastases and/or Tumor Extension beyond the Thyroid Capsule at Initial Diagnosis
|The Journal of Clinical Endocrinology & Metabolism|2005|589
A Comparison of Recombinant Human Thyrotropin and Thyroid Hormone Withdrawal for the Detection of Thyroid Remnant or Cancer1
|The Journal of Clinical Endocrinology & Metabolism|1999|564